Fact CheckerSign in

NCT06541210Recruiting

Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men

Building Community Living Labs (CoLLab) in Black Communities With the Goal of Advancing Prostate Health Equity and Reducing Prostate Cancer Disparities in Black Men

Source: ClinicalTrials.gov · Last updated 29 Sept 2026

Brief summary (registry, in English)

This clinical trial the possibility of establishing a Community Living Labs (CoLLab) Learning Health System to facilitate access to prostate health Risk, Education, and Assessment in the Community with Help (REACH) services in Black men and compares the impact to American Legion Posts with no CoLLab set up at the individual and community levels. Cancer is the second leading cause of death for Black men and Black men are less likely to receive prostate cancer screening. CoLLab Learning Health System utilizes community health workers (CHW) that are well-trained to form a bridge between communities and clinicians. In fact, Black men who work with CHW's typically have better access to health services, gain knowledge about cancer, cancer prevention, treatment and may have better overall health outcomes. Establishing a CoLLab Learning Health System at American Legion Posts may improve access to clinical trials and prostate cancer services in Black men.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
250 (estimated)
First submitted
2 Aug 2024
Start date
4 May 2024
Primary completion date
30 Sept 2027
Lead sponsor
Mayo Clinic
NCT number
NCT06541210

What you commit to

  • Study type: Interventional
  • Planned participants: 250
  • From 4 May 2024 to the primary completion date, 30 Sept 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • AIMS 1 AND 3: Younger than 21years or older than 80 years.
  • AIM 2: Younger than 30 years or older than 80 years.

Other

  • AIMS 1 AND 3: Not a resident of NE Florida. Unwilling or unable to consent to the study.
  • AIM 2: Not a resident of NE Florida.
  • AIM 2: Unwilling or unable to consent to the study.

Who the study is looking for

  • AIMS 1 AND 3: Participants must be one of the following key personnel:
    • Community PI (n=1),
    • CoLLab Program Manager (n=1)
    • CoLLab Site Managers (n=3)
    • CoLLab CAB members (n=21)
    • 2 Community Health Workers (CHWs) per Post site (n=6)
  • AIMS 1 AND 3: Between the ages of 21 and 80.
  • AIMS 1 AND 3: Able to complete the survey in English.
  • AIMS 1 AND 3: Reside in the Jacksonville, FL and/or surrounding counties.
  • AIMS 1 AND 3: Willing and able to consent to the study.
  • AIM 2: Black adult of any gender.
  • AIM 2: Must be between the ages of 30 and 80.
  • AIM 2: Able to speak English.
  • AIM 2: Reside in the Jacksonville, FL and/or surrounding counties.
  • AIM 2: Willing and able to consent to the study.

Age in the registry: 21 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mayo Clinic in Florida
Coordinator of this site? Confirm its status
JacksonvilleUnited StatesRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.